Gyeonggi-do, South Korea

Hyung Jun Im

This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung Jun Im. Retrieved from https://idiyas.com/inventor/hyung-jun-im-08nw91o3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyung Jun Im: Innovator in Drug Delivery Systems

Introduction

Hyung Jun Im is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative methods for analyzing the efficiency of drug delivery particles.

Latest Patents

Hyung Jun Im holds a patent titled "Method for analyzing endosomal escape efficiency of drug delivery particles." This method quantitatively analyzes the endosomal escape efficiency by measuring magnetic resonance signals reflected upon the emission of electromagnetic waves into cells that have ingested iron oxide-carrying particles. The process utilizes a magnetic resonance imaging device to obtain a change rate of magnetic relaxation over time from the measurements. He has 1 patent to his name.

Career Highlights

Hyung Jun Im is affiliated with Seoul National University, where he conducts research and develops innovative solutions in the field of drug delivery. His work has garnered attention for its potential to enhance the effectiveness of therapeutic agents.

Collaborations

He collaborates with notable colleagues, including Jeong Bin Park and So Min Lee, who contribute to his research endeavors and help advance the field of drug delivery systems.

Conclusion

Hyung Jun Im's innovative approach to drug delivery analysis positions him as a key figure in the advancement of medical technology. His contributions are paving the way for more effective therapeutic solutions in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…